Large Scale ICU Data Sharing for 1000 Critically Ill Patients With Severe Acute Respiratory Distress Syndrome Coronavirus (SARS.COV19) in Three Distinct Isolation Centers

Median Nerve Entrapement Clinical Trial

Official title:

Large Scale ICU Data Sharing for 1000 Critically Ill Patients With Severe Respiratory Distress Syndrome Coronavirus in Three Distinct Isolation Centers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04779268
• Other study ID #: 181/2-2021
• Status: Completed
• Start date: May 1, 2020
• Est. completion date: December 10, 2020

Study information

• Verified date: April 2022
• Source: Minia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Cohort study of patients with severe respiratory distress syndrome coronavirus2 in three different isolation hospitals recording data about outcome.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: December 10, 2020
• Est. primary completion date: November 26, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 70 Years

Eligibility

Inclusion Criteria:

• All COVID positive candidates

Exclusion Criteria:

• patient refusal

Related Conditions & MeSH terms

• Median Nerve Entrapement
• Respiratory Distress Syndrome
• Respiratory Distress Syndrome, Newborn

Locations

Country	Name	City	State
Egypt	Mina Raouf	Minia

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	follow up	mortality, length of ICU stay, ( days)	3 months
Secondary	prediction	prediction of mortality and morbidity	3 months